Claritev Corporation (CTEV)

Market Cap	677.88M
Revenue (ttm)	951.00M
Net Income (ttm)	-341.68M
Shares Out	16.53M
EPS (ttm)	-20.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220,314
Open	41.43
Previous Close	41.11
Day's Range	40.43 - 41.73
52-Week Range	5.61 - 74.07
Beta	0.53
Analysts	Strong Buy
Price Target	83.00 (+102.34%)
Earnings Date	Nov 7, 2025

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 2,700
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2024, Claritev's revenue was $930.62 million, a decrease of -3.21% compared to the previous year's $961.52 million. Losses were -$1.65 billion, 1694.9% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for CTEV stock is "Strong Buy." The 12-month stock price target is $83.0, which is an increase of 102.34% from the latest price.

Price Target

$83.0

(102.34% upside)

Analyst Consensus: Strong Buy